What is the ICD-10 (International Classification of Diseases, 10th Revision) code for cervical cancer screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for Cervical Cancer Screening

The ICD-10 code for routine cervical cancer screening in an asymptomatic woman is Z12.4 (Encounter for screening for malignant neoplasm of cervix).

Primary Screening Code

  • Z12.4 is the appropriate code for encounters specifically for cervical cancer screening, including Pap tests, HPV testing, or co-testing in asymptomatic women who are presenting for routine screening 1, 2, 3.

Additional Relevant Codes

When documenting cervical cancer screening encounters, you may also need to consider:

  • Z11.51 - Encounter for screening for human papillomavirus (HPV), which can be used when HPV testing is the primary focus of the visit 1, 2.

  • Z87.410 - Personal history of cervical dysplasia, which should be used for women with a history of abnormal findings who require more intensive surveillance rather than routine screening 4.

  • Z77.9 - Contact with and (suspected) exposure to unspecified hazardous, chiefly nonmedicinal, chemicals, may be relevant for women with DES exposure requiring continued screening 4.

Important Coding Considerations

The screening code Z12.4 should only be used for asymptomatic women presenting for routine preventive screening. If a woman presents with symptoms (such as abnormal bleeding, discharge, or pelvic pain), the appropriate symptom code should be used instead, not the screening code 4.

For women presenting for follow-up of previously abnormal results, use the appropriate code for the abnormal finding (such as codes from the R87 series for abnormal cervical cytology findings) rather than the screening code 4.

Women who have had a total hysterectomy with cervix removal for benign disease should not receive screening and therefore Z12.4 would not be appropriate for these patients 4, 5.

References

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.